Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.3098
+0.0098 (3.27%)
May 18, 2026, 1:40 PM EST

Avenue Therapeutics Revenue

Avenue Therapeutics had revenue of $1.40M in the twelve months ending March 31, 2026. In the year 2025, Avenue Therapeutics had annual revenue of $1.40M.

Revenue
1.40M
Revenue Growth
n/a
P/S Ratio
0.73
Revenue / Employee
1.40M
Employees
1
Market Cap
1.02M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.40M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Evofem Biosciences20.24M
Emmaus Life Sciences12.03M
Lyra Therapeutics398.00K
Eastgate Biotech137.64K
Halberd6.94K
Revenue Rankings